EUCTR2011-002563-23-PL进行中（未招募）不适用
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease - SPRING
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Age 45 through 75 years.
- •- Predicted (GOLD stage II, III, and IV) at screening.
- •- History of previous AECOPD 12 months prior to screening Clinically stable and free from an AECOPD for 8 weeks prior to Day 1.
- •- Current smoker or ex-smoker with a tobacco history of = 10 pack-years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 230
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 70
排除标准
- •- Past or present disease or disorder,
- •- Significant or unstable ischemic heart disease, etc
- •- Known history of allergy or reaction to any component of the IMP
- •- Past or current malignancy within the past 5 years
- •- Subjects have had a chest x-ray or CT scan suggestive of malignancy or tuberculosis (TB).
- •- Use of immunosuppressive medication receipt of any biologic agent
研究者
相似试验
进行中（未招募）
不适用
A Phase 2 study to test how effective MEDI8968 is in treating subjects with chronic bronchitis, emphysema, or both, in which airflow to the lungs is restricted.Chronic Obstructive Pulmonary DiseaseMedDRA version: 14.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-002563-23-LTMedImmune Limited300
进行中（未招募）
不适用
A Phase 2 study to test how effective MEDI8968 is in treating subjects with chronic bronchitis, emphysema, or both, in which airflow to the lungs is restricted.Chronic Obstructive Pulmonary DiseaseEUCTR2011-002563-23-HUMedImmune Limited300
进行中（未招募）
1 期
A Phase 2 study to test how effective MEDI8968 is in treating subjects with chronic bronchitis, emphysema, or both, in which airflow to the lungs is restricted.Chronic Obstructive Pulmonary DiseaseEUCTR2011-002563-23-GBMedImmune Limited324
进行中（未招募）
不适用
A Phase 2 study to test how effective MEDI8968 is in treating subjects with chronic bronchitis, emphysema, or both, in which airflow to the lungs is restricted.Chronic Obstructive Pulmonary DiseaseMedDRA version: 14.0Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-002563-23-LVMedImmune Limited300
进行中（未招募）
1 期
A Phase 2 study to test how effective MEDI8968 is in treating subjects with chronic bronchitis, emphysema, or both, in which airflow to the lungs is restricted.Chronic Obstructive Pulmonary DiseaseEUCTR2011-002563-23-CZMedImmune Limited300